Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant, BCL-2, Allogeneic stem cell transplantation, Venetoclax and the tags rare, haematologic.
Shares Allogeneic stem cell transplantation, Rare and paediatric cancers without markets and the tags rare, haematologic.
Shares the tags rare, haematologic.
Shares JAK-STAT signalling, Ruxolitinib, Leukaemia (all types), Chronic lymphocytic leukaemia and the tags rare, haematologic.
Shares Multiparameter flow cytometry MRD, Chronic myeloid leukaemia (CML), RAS / RAF / MEK / ERK (MAPK), Leukaemia (all types) and the tag haematologic.
Shares JAK-STAT signalling, Clonal haematopoiesis (CHIP), Epigenetic reprogramming, Azacitidine and the tags rare, haematologic.
Shares Venetoclax, Leukaemia (all types), Chronic lymphocytic leukaemia and the tags rare, haematologic.
Shares Venetoclax, Leukaemia (all types), Chronic lymphocytic leukaemia and the tags rare, haematologic.
The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.